HopeStage
Back to all studies
CompletedEUCTR 2015-000323-86

A randomised, parallel group, double blind, placebo controlled, add on clinical trial to investigate whether the lithium mimetic, ebselen, can reduce symptoms of hypomania and mania in bipolar pati...

This historical record does not confirm current site availability.

Historical research recordAges 18–70United KingdomBipolarity
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Listed locations
OxfordSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 1, 2017
Recruitment status
Completed
Enrollment listed in the registry
60
Sponsor
University of Oxford
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United Kingdom
Age range
From 18 Years to 70 Years
Official registry ID
EUCTR 2015-000323-86
Official title
Show the full official title

A randomised, parallel group, double blind, placebo controlled, add on clinical trial to investigate whether the lithium mimetic, ebselen, can reduce symptoms of hypomania and mania in bipolar pati...

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Oxford

Registry detailsOriginal registry record (opens in a new tab)
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Oxford, a university.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies